WASHINGTON, Dec 20 (Reuters) - Genentech Inc has resolved a dispute with doctors over the use of its cancer drug Avastin, a much less costly alternative to the biotech company's Lucentis for macular ...
LONDON, June 11 (Reuters) - Roche's cancer drug Avastin is a cheap, effective treatment for preventing blindness and should be used routinely in countries that cannot afford the far more costly ...
8don MSN
Elderly patients living in remote parts of B.C. forced to travel to save their sight — or pay
Elderly people living on the Sunshine Coast who need eye injections in order to maintain their sight are having to pay out of ...
Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. Outlook Therapeutics has been trying to get an official approval for a reformulated ...
The Department of Veterans Affairs said it has stopped using the drug Avastin to treat eye disease, as it investigates concerns about serious infections and blindness from the drug, according to a ...
Dear Dr. Roach: I was diagnosed with stage 1 bladder cancer in April. My urologist advised me to have BCG therapy for it. I just completed six weeks of the therapy. I also have macular degeneration in ...
Outlook Therapeutics’ second attempt to market an ophthalmic version of Roche’s tried-and-true Avastin in the U.S. has been knocked back by the FDA. In a new complete response letter, the FDA has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback